News
GSK Plc won US approval for its drug to treat a deadly lung disease, ramping up competition with rival Sanofi.
GSK aims to expand its Stevenage facility to create one of the largest life sciences sites in Europe. The future of the giant drug maker is at stake as its boss faces one of her biggest challenges.
GSK’s new office on New Oxford St will bring the firm closer to its other London-based divisions and strategic partners London-based staff at GSK will have enjoyed a considerably shorter commute ...
GSK's recently-unveiled plan to develop a bioscience cluster close to its main R&D site in Stevenage, UK, has moved closer to fruition, now that the first partners have joined the initiative.
A scientist from Stevenage has been announced as a finalist at the Black British Business Awards 2023. Dr Azzedine Dabo is an investigator at GSK, and is one of three people shortlisted for the ...
Stevenage Borough Council’s planning and development committee approved the plans, which would be located alongside drugs giant GlaxoSmithKline's global research and development facility and ...
The positive decision came from Stevenage Borough Council’s planning committee and will pave the way for a new life sciences hub. The development will be delivered alongside GSK’s existing global R&D ...
office and research facilities next to GlaxoSmithKline's (GSK) existing base, south of Stevenage town centre. Billed as one of Europe’s largest life science clusters, the project aims to bring ...
ft of lab, office and Good Manufacturing Practices (GMP) facilities The new ‘Elevate Quarter’ campus will be located alongside GSK’s existing Global R&D facility and Stevenage Bioscience Catalyst, and ...
Melanie is the Senior Director at GSK (Stevenage, UK) leading the Screening, Profiling and Mechanistic Biology team, which provides assay development, high-throughput screening and mechanistic biology ...
GSK has overhauled R&D dept since Walmsley became ... Investor concerns over GSK pipeline reflect in share price-analysts STEVENAGE, England, March 15 (Reuters) - GSK's (GSK.L), opens new tab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results